Erenumab for chronic cluster headache: A case report
The preventive treatment for cluster headache is often limited by a lack of efficacy or side effects. Calcitonin gene-related peptide (CGRP) has been implicated in the pathophysiology of cluster headache. Galcanezumab, a monoclonal antibody against calcitonin gene-related peptide (CGRP), significant...
Main Authors: | Franz Riederer, Allyson M Wenner |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-08-01
|
Series: | Cephalalgia Reports |
Online Access: | https://doi.org/10.1177/2515816320947713 |
Similar Items
-
Menstrual Headache in Women with Chronic Migraine Treated with Erenumab: An Observational Case Series
by: Raffaele Ornello, et al.
Published: (2021-03-01) -
Treatment of posttraumatic headache migraine phenotype with erenumab – An observational study
by: James A Charles
Published: (2019-09-01) -
The role of erenumab in the treatment of migraine
by: Anna P. Andreou, et al.
Published: (2020-05-01) -
Early onset of efficacy with erenumab in patients with episodic and chronic migraine
by: Todd Schwedt, et al.
Published: (2018-10-01) -
A prospective real-world analysis of erenumab in refractory chronic migraine
by: Giorgio Lambru, et al.
Published: (2020-06-01)